PMID: 21143116

He SM, Li R, Kanwar JR, Zhou SF
Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
Curr Med Chem. 2011;18(3):439-81., [PubMed]
Sentences
No. Mutations Sentence Comment
335 ABCC2 p.Leu23Arg
X
ABCC2 p.Leu23Arg 21143116:335:134
status: NEW
view ABCC2 p.Leu23Arg details
ABCC2 p.Leu23Pro
X
ABCC2 p.Leu23Pro 21143116:335:121
status: NEW
view ABCC2 p.Leu23Pro details
Some other NSAIDs including sulindac were found to have a similar effect in human lung cancer cell lines DLKP, A549, COR L23P and COR L23R and in a human leukaemia line HL60/ADR [229], although it is unrelated to the action of these drugs on cyclooxygenases. Login to comment
654 ABCC1 p.Asp793Glu
X
ABCC1 p.Asp793Glu 21143116:654:4
status: NEW
view ABCC1 p.Asp793Glu details
ABCC1 p.Glu1455Asp
X
ABCC1 p.Glu1455Asp 21143116:654:77
status: NEW
view ABCC1 p.Glu1455Asp details
The Asp793Glu mutation in NBD1 enhanced its hydrolytic capacity, whereas the Glu1455Asp mutation in NBD2 resulted in an increased affinity of NBD2 for ATP, but a decreased hydrolytic activity [322]. Login to comment
671 ABCC1 p.Asp793Glu
X
ABCC1 p.Asp793Glu 21143116:671:4
status: NEW
view ABCC1 p.Asp793Glu details
The Asp793Glu mutant of NBD1 showed increased hydrolytic capacity but had occlusion of the resultant ADP in the absence of vanadates [322]. Login to comment
673 ABCC1 p.Glu1455Asp
X
ABCC1 p.Glu1455Asp 21143116:673:4
status: NEW
view ABCC1 p.Glu1455Asp details
The Glu1455Asp mutant with a reciprocal mutation of NBD2 exhibited an increased affinity for both azido-ATP and -ADP. Login to comment
711 ABCC1 p.Glu1089Gln
X
ABCC1 p.Glu1089Gln 21143116:711:196
status: NEW
view ABCC1 p.Glu1089Gln details
More NH2-proximal regions of TMD1 also appear to be involved in LY475776 binding since tryptic fragments corresponding to TM12/13 and TM14/15 are photolabeled, and photolabeling is reduced in the Glu1089Gln mutant of TM14 [270, 271]. Login to comment
720 ABCC1 p.Trp222Leu
X
ABCC1 p.Trp222Leu 21143116:720:71
status: NEW
view ABCC1 p.Trp222Leu details
ABCC1 p.Trp223Leu
X
ABCC1 p.Trp223Leu 21143116:720:82
status: NEW
view ABCC1 p.Trp223Leu details
ABCC1 p.Arg230Ala
X
ABCC1 p.Arg230Ala 21143116:720:96
status: NEW
view ABCC1 p.Arg230Ala details
Membrane vesicles prepared from cells expressing mutated MRP1/ABCC1 at Trp222Leu, Trp223Leu, or Arg230Ala within L0 could transport SN-38 (active metabolite of irinotecan), but not LTC4 or E217 G which are transported by MRP1/ABCC1 in a GSH-dependent manner, and could not be photolabeled with 11-azidophenyl agosterol A [279]. Login to comment
726 ABCC1 p.Glu1144Ala
X
ABCC1 p.Glu1144Ala 21143116:726:1103
status: NEW
view ABCC1 p.Glu1144Ala details
ABCC1 p.Asp1179Ala
X
ABCC1 p.Asp1179Ala 21143116:726:1185
status: NEW
view ABCC1 p.Asp1179Ala details
ABCC1 p.Lys1181Ala
X
ABCC1 p.Lys1181Ala 21143116:726:1210
status: NEW
view ABCC1 p.Lys1181Ala details
ABCC1 p.Arg1166Ala
X
ABCC1 p.Arg1166Ala 21143116:726:1160
status: NEW
view ABCC1 p.Arg1166Ala details
These include Cys43 in TM1 [171], Thr73 in CL1 [366], Trp222 in L0 [279], Trp223 in L0 [279], Arg230 in L0 [279], Trp261 in L0 [271, 302, 338], Lys267 in L0 [271, 302, 338], Lys319 in TM6 [339], Tyr324 in TM6 [301], Lys332 in TM6 [166, 339-341], His335 in TM6, Asp336 in TM6 [339], Lys347 in TM6 [339], Lys396 in TM7 [339], Arg433 in TM8 [363], Asp436 in TM8 [339], Trp445 in TM8, Trp459 in TM8, Pro478 in TM9, Thr550 in TM10 [343], Trp553 in TM10 [344], Thr556 in TM10 [343], Pro557 in TM10 [345], Tyr568 in TM10 [343], Arg593 in TM11 [339], Phe594 in TM11 [300], Asn597 in TM11, Ser604 in TM11, Ser605 in TM11, Trp653 in NBD1 [351], Lys684 in Walker A motif of NBD1 [350, 364], Ser685 in Walker A motif of NBD1 [353], Arg723 in NBD1 [366], Gly771 in the ABC signature (C motif) of NBD1 [364], Asp792 in Walker B motif of NBD1 [361], Asp793 in Walker B motif of NBD1 [353], Ala989 in TM12 [367], Pro1120 in TM13, Pro1121 in TM13, Arg1058 at TM13/CL6 interface [366], Glu1089 in TM14, Lys1092 in TM14, Ser1097 in TM14, Asn1100 in TM14, Arg1138 in TM15 [354], Lys1141 in CL7 [354], Arg1142 in CL7 [354], Glu1144Ala in CL7 [355], Pro1150 in CL7 [345, 347, 348], Arg1166Ala in CL7 [355], Asp1179Ala in CL7 [355], Lys1181Ala in CL7 [355], Asp1183 in CL7 [355], Tyr1189 in CL7 [368], Tyr1190 in CL7 [368], Arg1197 in TM16 [357], Trp1198 in TM16 [344], Arg1202 in TM16 [357], Glu1204 in TM16 [357], Tyr1236 in TM17, Thr1241 in TM17, Thr1242 in TM17, Tyr1243 in TM17, Asn1245 in TM17, Trp1246 in TM17 [166, 339-341], Arg1249 in TM17 [342], Tyr1302 in NBD2 [351], Lys1333 in Walker A motif of NBD2 [350], Gly1433 in the ABC signature motif of NBD2 [352, 364], Glu1455 in Walker B motif of NBD2 [322], and His1486 in NBD2 [349]. Login to comment
735 ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 21143116:735:39
status: NEW
view ABCC1 p.Arg433Ser details
The naturally occurring replacement of Arg433 by Ser (neutral) at the interface of CL4 and TM8 caused a 2-fold decrease in LTC4 and estrone sulfate transport but were 2.1-fold more resistant to doxorubicin while while resistance to etoposide (VP-16) and vincristine remained unchanged [363]. Login to comment
739 ABCC1 p.Arg1138Glu
X
ABCC1 p.Arg1138Glu 21143116:739:105
status: NEW
view ABCC1 p.Arg1138Glu details
In contarst, the mutations showed minor to moderate effect on MTX transport, with a maximum decrease for Arg1138Glu). Login to comment
742 ABCC1 p.Lys1141Arg
X
ABCC1 p.Lys1141Arg 21143116:742:21
status: NEW
view ABCC1 p.Lys1141Arg details
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:742:21
status: NEW
view ABCC1 p.Lys1141Glu details
Notably, mutation of Lys1141 to either Glu or Arg impaired MRP1/ABCC1 expression and routing to the plasma membrane [354]. Login to comment
743 ABCC1 p.Lys1141Arg
X
ABCC1 p.Lys1141Arg 21143116:743:216
status: NEW
view ABCC1 p.Lys1141Arg details
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:743:16
status: NEW
view ABCC1 p.Lys1141Glu details
ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:743:201
status: NEW
view ABCC1 p.Lys1141Glu details
Substitution of Lys1141 with Glu (negatively chages) at TM15/CL7 interface decreased LTC4 transport by 70%, but an Arg substitution (positively charged) at this position did not; GSH transport by both Lys1141Glu and Lys1141Arg mutants was decreased by 40%, suggesting that the presence of a positive charge at Lys1141 was sufficient for LTC4 transport, whereas the less bulky side chain of Lys itself seemed important for GSH transport [354]. Login to comment
744 ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:744:19
status: NEW
view ABCC1 p.Lys1141Glu details
ABCC1 p.Arg1138Lys
X
ABCC1 p.Arg1138Lys 21143116:744:51
status: NEW
view ABCC1 p.Arg1138Lys details
ABCC1 p.Arg1138Glu
X
ABCC1 p.Arg1138Glu 21143116:744:4
status: NEW
view ABCC1 p.Arg1138Glu details
ABCC1 p.Arg1142Glu
X
ABCC1 p.Arg1142Glu 21143116:744:63
status: NEW
view ABCC1 p.Arg1142Glu details
ABCC1 p.Arg1142Lys
X
ABCC1 p.Arg1142Lys 21143116:744:79
status: NEW
view ABCC1 p.Arg1142Lys details
The Arg1138Glu and Lys1141Glu mutants, but not the Arg1138Lys, Arg1142Glu, and Arg1142Lys mutants, showed a >50% decrease in binding to [3 H]LTC4. Login to comment
745 ABCC1 p.Lys1141Arg
X
ABCC1 p.Lys1141Arg 21143116:745:19
status: NEW
view ABCC1 p.Lys1141Arg details
All mutants except Lys1141Arg showed substantially reduced trapping of 8-azido-[ 32P]ATP (40-60% that of wild-type MRP1), implicating that the ability of these mutants at TM15/CL7 interface to hydrolyze ATP is impaired and consequently disrupt the transport cycle and cause a decrease in transport activity. Login to comment
751 ABCC1 p.Pro51Ala
X
ABCC1 p.Pro51Ala 21143116:751:53
status: NEW
view ABCC1 p.Pro51Ala details
ABCC1 p.Pro42Ala
X
ABCC1 p.Pro42Ala 21143116:751:44
status: NEW
view ABCC1 p.Pro42Ala details
The transport activity of the double mutant Pro42Ala/Pro51Ala was reduced by >80%. Login to comment
755 ABCC1 p.Pro1150Ala
X
ABCC1 p.Pro1150Ala 21143116:755:40
status: NEW
view ABCC1 p.Pro1150Ala details
Compared with wild-type MRP1/ABCC1, the Pro1150Ala mutant showed decreased LTC4, estrone sulfate, and GSH transport but substantially increased E217 G and MTX transport [345]. Login to comment
757 ABCC1 p.Pro1150Ala
X
ABCC1 p.Pro1150Ala 21143116:757:15
status: NEW
view ABCC1 p.Pro1150Ala details
In the case of Pro1150Ala mutant, vanadate-induced trapping of [ 32 P]8N3ADP was greatly diminished relative to wild-type MRP1, while photolabeling of this mutant with [ 32 P]8N3ATP under nonhydrolytic conditions remained unchanged [345]. Login to comment
758 ABCC1 p.Pro1150Ala
X
ABCC1 p.Pro1150Ala 21143116:758:99
status: NEW
view ABCC1 p.Pro1150Ala details
ABCC1 p.Pro1150Leu
X
ABCC1 p.Pro1150Leu 21143116:758:28
status: NEW
view ABCC1 p.Pro1150Leu details
ABCC1 p.Pro1150Gly
X
ABCC1 p.Pro1150Gly 21143116:758:4
status: NEW
view ABCC1 p.Pro1150Gly details
ABCC1 p.Pro1150Val
X
ABCC1 p.Pro1150Val 21143116:758:43
status: NEW
view ABCC1 p.Pro1150Val details
ABCC1 p.Pro1150Ile
X
ABCC1 p.Pro1150Ile 21143116:758:16
status: NEW
view ABCC1 p.Pro1150Ile details
The Pro1150Gly, Pro1150Ile, Pro1150Leu and Pro1150Val mutants exhibited a phenotype similar to the Pro1150Ala mutant with respect to organic anion transport and [ 32 P]8N3ATP photolabeling [347]. Login to comment
763 ABCC1 p.Trp1246Phe
X
ABCC1 p.Trp1246Phe 21143116:763:29
status: NEW
view ABCC1 p.Trp1246Phe details
In contrast, substitution of Trp1246 with Phe, Tyr, Ala, or Cys selectively eliminated E217 G and NNAL-O-glucuronide transport and drug resistance but showed little or no effect on LTC4 and GSH transport [166, 341, 371]. Login to comment
765 ABCC1 p.Trp1246Cys
X
ABCC1 p.Trp1246Cys 21143116:765:19
status: NEW
view ABCC1 p.Trp1246Cys details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:765:5
status: NEW
view ABCC1 p.Lys332Leu details
Both Lys332Leu and Trp1246Cys mutants were as sensitive as wild-type MRP1/ABCC1 to MK-571, LY171883, and the potent MRP1/ABCC1 inhibitor 6-[4 -carboxyphenylthio]-5[S]- hydroxy-7[E], 11[Z]14[Z]-eicosatetrenoic acid (BAY u9773, a leukotriene-like dual antagonist that acts on both CysLT1 and CysLT2 receptors) [341]. Login to comment
766 ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:766:121
status: NEW
view ABCC1 p.Lys332Leu details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:766:218
status: NEW
view ABCC1 p.Lys332Leu details
MK-571 and LY171883 were moderately (2-fold) less potent inhibitors of E217 G uptake by wild-type MRP1/ABCC1 than by the Lys332Leu mutant, but LY465803 showed 16-fold greater potency to inhibit wild-type compared with Lys332Leu mutant. Login to comment
767 ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:767:149
status: NEW
view ABCC1 p.Lys332Leu details
In a similar manner, the GSH derivative S-decyl-GSH and GSSG inhibited wild-type MRP1/ABCC1 activity with IC50 >100-fold and >30-fold lower than for Lys332Leu, respectively [341]. Login to comment
768 ABCC1 p.Trp1246Cys
X
ABCC1 p.Trp1246Cys 21143116:768:164
status: NEW
view ABCC1 p.Trp1246Cys details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:768:76
status: NEW
view ABCC1 p.Lys332Leu details
In contrast to its more potent inhibitory effect on E217 G transport by the Lys332Leu mutant, MK-571 was a less potent inhibitor ( 3-fold) of LTC4 transport by the Trp1246Cys mutant than by wild-type MRP1. Login to comment
769 ABCC1 p.Trp1246Cys
X
ABCC1 p.Trp1246Cys 21143116:769:106
status: NEW
view ABCC1 p.Trp1246Cys details
ABCC1 p.Lys332Leu
X
ABCC1 p.Lys332Leu 21143116:769:20
status: NEW
view ABCC1 p.Lys332Leu details
However, similar to Lys332Leu, the inhibitory potency of BAY u9773 for LTC4 transport by wild-type and Trp1246Cys was comparable. Login to comment
781 ABCC1 p.Trp361Ala
X
ABCC1 p.Trp361Ala 21143116:781:0
status: NEW
view ABCC1 p.Trp361Ala details
Ala substitution of Trp361 in TM7 and Trp459 in TM9 only resulted in more moderate changes in trasnport activity. Login to comment
792 ABCC1 p.Tyr440Phe
X
ABCC1 p.Tyr440Phe 21143116:792:4
status: NEW
view ABCC1 p.Tyr440Phe details
The Tyr440Phe mutant expressed in Sf21 cells showed a 5-fold higher Km for LTC4 and substantially reduced photolabeling of MRP1/ABCC1 by both [3 H]LTC4 and the GSH derivative, azidophenacyl-[35 S]GSH [374]. Login to comment
794 ABCC1 p.Tyr440Phe
X
ABCC1 p.Tyr440Phe 21143116:794:17
status: NEW
view ABCC1 p.Tyr440Phe details
ABCC1 p.Tyr440Phe
X
ABCC1 p.Tyr440Phe 21143116:794:139
status: NEW
view ABCC1 p.Tyr440Phe details
ABCC1 p.Ile441Leu
X
ABCC1 p.Ile441Leu 21143116:794:28
status: NEW
view ABCC1 p.Ile441Leu details
ABCC1 p.Met443Leu
X
ABCC1 p.Met443Leu 21143116:794:39
status: NEW
view ABCC1 p.Met443Leu details
In addition, the Tyr440Phe, Ile441Leu, Met443Leu mutations decreased resistance to vincristine and etoposide 2-to 3-fold, whereas only the Tyr440Phe mutant displayed a major decrease in resistance to doxorubicin [374]. Login to comment
806 ABCC1 p.Lys1141Glu
X
ABCC1 p.Lys1141Glu 21143116:806:15
status: NEW
view ABCC1 p.Lys1141Glu details
Replacement of Lys1141 with Glu also impaired the expression of MRP1/ABCC1 at the plasma membrane and reduced its transport activity. Login to comment
807 ABCC1 p.Gly1161Pro
X
ABCC1 p.Gly1161Pro 21143116:807:31
status: NEW
view ABCC1 p.Gly1161Pro details
ABCC1 p.Glu1157Leu
X
ABCC1 p.Glu1157Leu 21143116:807:20
status: NEW
view ABCC1 p.Glu1157Leu details
The double-mutant Glu1157Leu/Gly1161Pro showed no activity for LTC4 and was not labeled by the photoaffinity ligand azidoAgosterol A [365]. Login to comment
809 ABCC1 p.Asp1183Ala
X
ABCC1 p.Asp1183Ala 21143116:809:19
status: NEW
view ABCC1 p.Asp1183Ala details
ABCC1 p.Arg1166Ala
X
ABCC1 p.Arg1166Ala 21143116:809:4
status: NEW
view ABCC1 p.Arg1166Ala details
The Arg1166Ala and Asp1183Ala/Glu mutants were poorly expressed, probably by affecting the proper folding of the protein during its biosynthesis. Login to comment
813 ABCC1 p.Glu1144Ala
X
ABCC1 p.Glu1144Ala 21143116:813:19
status: NEW
view ABCC1 p.Glu1144Ala details
ABCC1 p.Asp1179Ala
X
ABCC1 p.Asp1179Ala 21143116:813:31
status: NEW
view ABCC1 p.Asp1179Ala details
ABCC1 p.Lys1181Ala
X
ABCC1 p.Lys1181Ala 21143116:813:47
status: NEW
view ABCC1 p.Lys1181Ala details
The single mutants Glu1144Ala, Asp1179Ala, and Lys1181Ala) and the triple mutant 1169AAQA showed only moderate and substrate-selective changes in transport activity [355]. Login to comment
816 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 21143116:816:88
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:816:225
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:816:105
status: NEW
view ABCC1 p.Thr73Ile details
ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:816:366
status: NEW
view ABCC1 p.Arg1058Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 21143116:816:206
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 21143116:816:188
status: NEW
view ABCC1 p.Arg433Ser details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 21143116:816:346
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Val353Met
X
ABCC1 p.Val353Met 21143116:816:156
status: NEW
view ABCC1 p.Val353Met details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 21143116:816:327
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 21143116:816:122
status: NEW
view ABCC1 p.Ser92Phe details
ABCC1 p.Arg230Asn
X
ABCC1 p.Arg230Asn 21143116:816:139
status: NEW
view ABCC1 p.Arg230Asn details
ABCC1 p.Val1146Ile
X
ABCC1 p.Val1146Ile 21143116:816:385
status: NEW
view ABCC1 p.Val1146Ile details
ABCC1 p.Thr1401Met
X
ABCC1 p.Thr1401Met 21143116:816:469
status: NEW
view ABCC1 p.Thr1401Met details
ABCC1 p.Thr1337Ala
X
ABCC1 p.Thr1337Ala 21143116:816:404
status: NEW
view ABCC1 p.Thr1337Ala details
ABCC1 p.Ala861Thr
X
ABCC1 p.Ala861Thr 21143116:816:293
status: NEW
view ABCC1 p.Ala861Thr details
There are at least 15 naturally occurring mutations identified in MRP1/ABCC1, including Cys43Ser in TM1, Thr73Ile in CL1, Ser92Phe in TM2, Arg230Asn in L0, Val353Met at TM6/TM7 interface, Arg433Ser in TM8, Gly671Val in TM11, Arg723Gln located between the Walker A and Walker B motifs of NBD1, Ala861Thr at NBD1/TM12 interface, Ala989Thr in TM12, Cys1047Ser in TM13, Arg1058Gln in CL7, Val1146Ile in CL7, Thr1337Ala between the Walker A and Walker B motifs of NBD2, and Thr1401Met, and many of them have been found to affect its transport activity [171, 362, 363, 366, 367, 377-384]. Login to comment
818 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 21143116:818:4
status: NEW
view ABCC1 p.Cys43Ser details
The Cys43Ser mutant in TM1 (128G>C in exon 2) exhibited impaired plasma membrane location of the transporter, with a 2.5-fold decrease in arsenite resistance and a lower vincristine resistance [171]. Login to comment
819 ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 21143116:819:61
status: NEW
view ABCC1 p.Arg433Ser details
A naturally-occurring mutation of 1299G>T in exon 10 causing Arg433Ser in TM8 of TMD1 resulted in decreased transport of LTC4 and increased resistance to doxorubicin [363]. Login to comment
820 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 21143116:820:5
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:820:25
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:820:15
status: NEW
view ABCC1 p.Thr73Ile details
ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:820:40
status: NEW
view ABCC1 p.Arg1058Gln details
When Cys43Ser, Thr73Ile, Arg723Gln, and Arg1058Gln were separately transfected in CHO-K1 or HEK293 cells, the cells displayed altered resistance profiles to a panel of anticancer drugs compared to the wild-type [366]. Login to comment
821 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:821:17
status: NEW
view ABCC1 p.Arg723Gln details
In HEK293 cells, Arg723Gln confers lower resistance to all drugs compared with wild-types. Login to comment
822 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:822:17
status: NEW
view ABCC1 p.Arg723Gln details
In CHO-K1 cells, Arg723Gln significantly decreased resistance to all drugs tested except cisplatin, paclitaxel and MTX. Login to comment
823 ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:823:4
status: NEW
view ABCC1 p.Arg1058Gln details
The Arg1058Gln mutant showed a significant decrease in resistance to anthracyclines and etoposide in HEK293 cells [366]. Login to comment
824 ABCC1 p.Arg1058Gln
X
ABCC1 p.Arg1058Gln 21143116:824:21
status: NEW
view ABCC1 p.Arg1058Gln details
In CHO-K1 cells, the Arg1058Gln mutant conferred a lower resistance to vinblastine, anthracyclines, etoposide and MTX. Login to comment
825 ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:825:21
status: NEW
view ABCC1 p.Thr73Ile details
In HEK293 cells, the Thr73Ile mutation displayed a lower resistance to vincristine and MTX [366]. Login to comment
828 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 21143116:828:36
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Thr73Ile
X
ABCC1 p.Thr73Ile 21143116:828:63
status: NEW
view ABCC1 p.Thr73Ile details
For example, the frequencies of the Arg723Gln A allele and the Thr73Ile T allele in Chinese population were higher than the Caucasians [366]. Login to comment